EE671 Cost-Effectiveness of Pembrolizumab as an Adjuvant Treatment for Renal Cell Carcinoma Post-Nephrectomy in France
Abstract
Authors
M. Apert L. Bensimon L. Marié M. Chau G. Baluni N. Chhabra A. Kundu R. Bhattacharya Y. Lai M. Gross-Goupil I. Ouzaid